Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Cosmetic – antiperspirant – dentifrice
Reexamination Certificate
2002-04-01
2003-07-01
Page, Thurman K. (Department: 1615)
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Cosmetic, antiperspirant, dentifrice
C424S059000, C424S060000, C424S078060
Reexamination Certificate
active
06585988
ABSTRACT:
BACKGROUND OF THE INVENTION
1. Field of the Invention
This invention relates to cosmetic and human and animal health compositions, and, more particularly, to the reaction product of arginine and p-aminobenzoic acid (PABA), and compositions thereof, useful for treating wounds, lesions, burns, sunburn, the hair and scalp, hemorrhoids and teeth, in animals and humans, including bovine mastitis.
2. Description of the Prior Art
The prior art does not disclose the reaction product of arginine and p-aminobenzoic acid (PABA), and cosmetic and health compositions and formulations thereof. For example, U.S. Pat. No. 4,499,067 discloses only acyl arginine derivatives without PABA; U.S. Pat. No. 4,921,939 discloses only forming guanidine sweetening agents by reaction of substituted arcyl amines with guanidino moieties; U.S. Pat. No. 5,110,797 discloses peptide substituted/reacted arginine, however, without PABA; and U.S. Pat. No. 5,298,647 discloses PABA/amino acid reaction products which may be used as ultraviolet protecting agents, but arginine is not disclosed.
SUMMARY OF THE INVENTION
A method of controlling the regulatory mechanism in humans that governs cell division in a damaged cell structure which comprises reactivating the proliferative phase regulated by DNA, to enable the damaged cell to redifferentiate itself according to its basic genetic code, by administering to the human the reaction product of arginine and p-aminobenzoic acid.
DETAILED DESCRIPTION OF THE INVENTION
The composition of the invention comprises the formulation given in Table 1 below:
TABLE 1
Composition of Invention
Percent by Wt.
Component
Suitable
Preferred
Optimum
Reaction product of
0.5-10
1-5
2.29
arginine and p-aminobenzoic
acid (PABA) (as a powder,
aqueous solution, gel or
emulsion for example)
Biotin
0-0.05
0.01-0.2
0.0066
Calcium Pantothenate
0-5
0.1-0.5
0.33
Myoinositol
0-1.0
0.1-0.5
0.33
The reaction product of arginine and PABA is prepared as follows:
REFERENCES:
patent: 6365167 (2002-04-01), Schutt
Epicare Ltd.
Katz Walter
LandOfFree
Reaction product of arginine and p-aminobenzoic acid,... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Reaction product of arginine and p-aminobenzoic acid,..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Reaction product of arginine and p-aminobenzoic acid,... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3069055